Ticker reaction data

SENZIME AB ORD (SNZZF)

News Quantified tracks SNZZF headlines — 61 labeled events over the last three years — but too few produced usable price reactions to publish stable medians. The events themselves are below.

The quantified answer

Not enough usable reactions to publish SNZZF medians.

61 SNZZF events are labeled, but too few carry a measurable price reaction for a median to mean anything. When enough reactions accumulate, the medians publish here the same way as every other name.

Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.

Next time, know first

Email me when SNZZF moves on news.

One email per qualifying move — the headline, the measured reaction, and how it compares to SNZZF's baseline. Nothing else.

▲ SNZZF Free · unsubscribe anytime
26M+ news records Operating since 2012 Methodology on SSRN ↗
Latest news

Recent SNZZF events, each with its measured reaction.

DateHeadlineEventSource5-minTo close
New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular MonitoringPress releaseACCESS Newswire——
Senzime Launches Industry-First Predictive Neuromuscular Monitoring TechnologyPress releaseACCESS Newswire+0.00%+0.00%
Senzime Reaffirms Its Target of Reaching Positive Cash Flow Within Q4 2026Press releaseACCESS Newswire——
Senzime Strengthens Financing to Support Strategic OEM Expansion and Path to ProfitabilityPress releaseACCESS Newswire——
Senzime Secures Additional Major US Hospital Network Contract, Expanding Adoption of its Next-generation Neuromuscular Monitoring TechnologyPress releaseACCESS Newswire——
Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMedPress releaseACCESS Newswire+0.00%+0.00%
Interim Report Q2 2026: Strong Sensor Sales and Improved Margins, Despite Continued U.S. Monitor Market HeadwindsPress releaseACCESS Newswire——
Senzime and Philips Medical Systems Enter Development and Commercialization PartnershipPress releaseACCESS Newswire——
Invitation to Presentations of Senzime's Second Quarter 2026 ReportPress releaseACCESS Newswire——
Senzime's TetraGraph System Receives ANVISA Regulatory Approval in BrazilPress releaseACCESS Newswire——
Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026Press releaseACCESS Newswire——
Senzime Strengthens Position in Pediatric Anesthesia by Securing Another Hospital Contract and Highlighting Positive Outcome DataPress releaseACCESS Newswire+0.00%+0.00%
Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG SensorPress releaseACCESS Newswire+0.00%+0.00%
From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph SystemPress releaseACCESS Newswire——
Bulletin From Annual General Meeting in Senzime AB (publ)Press releaseACCESS Newswire——
Senzime Strengthens U.S. Operations with New Leadership AppointmentsPress releaseACCESS Newswire——
Senzime Publishes Annual and Sustainability Report for 2025Press releaseACCESS Newswire——
Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the USPress releaseACCESS Newswire——
Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on TrackPress releaseACCESS Newswire——
Senzime Wins Expanded Contract Within Leading Southeastern US Hospital SystemPress releaseACCESS Newswire——
Invitation to Presentations of Senzime's First Quarter 2026 ReportPress releaseACCESS Newswire——
Notice of Annual General Meeting in Senzime AB (publ)Press releaseACCESS Newswire——
Senzime Secures Strategic Hospital Orders Within Leading US Integrated Healthcare Delivery NetworkPress releaseACCESS Newswire——
Senzime Launches TetraCom Connectivity Platform Enabling Universal Transmission of Anesthesia DataPress releaseACCESS Newswire+0.00%+0.00%
Senzime Q4 2025: Accelerated Growth and Continued Clear Path to ProfitabilityPress releaseACCESS Newswire——
Senzime Secures Credit Line Facility of 50 MSEKPress releaseACCESS Newswire——
Invitation to Presentations of Senzime's Q4 and Year-End Report 2025Press releaseACCESS Newswire——
Senzime Secures Major Ivy League US Hospital System ContractPress releaseACCESS Newswire——
Senzime Secures Major TetraGraph Order from Leading UK NHS Hospital SystemPress releaseACCESS Newswire——
Senzime Unveils the Next Set of Innovations in Neuromuscular Monitoring With the Launch of EMGINE SiriusPress releaseACCESS Newswire——
Senzime's Next-Generation TetraGraph System Receives Regulatory Approval in JapanPress releaseACCESS Newswire——
European Growth Virtual Investor Conference: Presentations Now Available for Online ViewingPress releaseGlobeNewswire——
Senzime Launches Medical Affairs Division and Education Platform to Drive Transformation in Anesthesia MonitoringPress releasePR Newswire——
Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor SalesPress releaseAccesswire——
New Number of Shares and Votes in Senzime AB (publ)Press releaseAccesswire——
Invitation to Presentation of Senzime's Third Quarter 2024 ReportPress releaseAccesswire——
Senzime Successfully Unveils Next-Generation TetraGraph® Quantitative Train-of-Four Monitor at ANESTHESIOLOGY® 2024; U.S. Shipments Begin Q4 2024Press releasePR Newswire+0.00%+0.00%
Bulletin From Extraordinary General Meeting in Senzime AB (publ)Press releaseAccesswire——
Senzime Secures First European Hospital Order for its New Next-Generation TetraGraph SystemPress releaseAccesswire——
New Clinical Study Confirms the Industry Leading Performance Of Senzime’s TetraGraph SystemPress releaseAccesswire——
Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 ConferencePress releaseAccesswire——
Notice of Extraordinary General Meeting in Senzime AB (publ)Press releaseAccesswire——
Senzime Secures New Contract With Leading US Healthcare SystemPress releaseAccesswire——
Interim Report January - June 2024: Strong Sales Growth in US MarketPress releaseAccesswire+0.00%+0.00%
Senzime Provides Market Update and Outlines High Growth AmbitionsPress releaseAccesswire+0.00%+0.00%
Invitation to Presentation of Senzime’s Second Quarter 2024 ReportPress releaseAccesswire——
Senzime Expands Contract with Leading US Hospital SystemPress releaseAccesswire——
Senzime Granted New European TetraGraph System PatentPress releaseAccesswire+0.00%+0.00%
Senzime Wins Contract with the Most Prestigious and Highest Ranked Children’s Hospital in the USPress releaseAccesswire+0.00%+0.00%
New Clinical Study Published in Anesthesiology Confirms the Leading Accuracy and Precision of Senzime's TetraGraph SystemPress releaseAccesswire——

Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SNZZF section they belong to.

Keep exploring

Where else SNZZF is measured.

SNZZF earnings → · Analyst actions → · SEC filings →

Every ticker we measure the same way24

Apple (AAPL)

How AAPL actually reacts to news, measured.

NVIDIA (NVDA)

How NVDA actually reacts to news, measured.

Tesla (TSLA)

How TSLA actually reacts to news, measured.

Microsoft (MSFT)

How MSFT actually reacts to news, measured.

Advanced Micro Devices (AMD)

How AMD actually reacts to news, measured.

Amazon (AMZN)

How AMZN actually reacts to news, measured.

Alphabet (GOOG)

How GOOG actually reacts to news, measured.

Meta Platforms (META)

How META actually reacts to news, measured.

Broadcom (AVGO)

How AVGO actually reacts to news, measured.

JPMorgan Chase (JPM)

How JPM actually reacts to news, measured.

Visa (V)

How V actually reacts to news, measured.

Walmart (WMT)

How WMT actually reacts to news, measured.

Eli Lilly (LLY)

How LLY actually reacts to news, measured.

UnitedHealth Group (UNH)

How UNH actually reacts to news, measured.

Netflix (NFLX)

How NFLX actually reacts to news, measured.

Johnson & Johnson (JNJ)

How JNJ actually reacts to news, measured.

Exxon Mobil (XOM)

How XOM actually reacts to news, measured.

Home Depot (HD)

How HD actually reacts to news, measured.

Costco (COST)

How COST actually reacts to news, measured.

Mastercard (MA)

How MA actually reacts to news, measured.

Oracle (ORCL)

How ORCL actually reacts to news, measured.

Salesforce (CRM)

How CRM actually reacts to news, measured.

Bank of America (BAC)

How BAC actually reacts to news, measured.

Coca-Cola (KO)

How KO actually reacts to news, measured.

Walt Disney (DIS)

How DIS actually reacts to news, measured.

Browse all tickers

Every name we’ve measured, in one place.

Stop guessing what the event means

You just saw one reaction.
There are 26 million more.

For investors

Know the next move, measured.

Ticker alerts with the realized reaction — not the headline spin.

Free · no credit card · unsubscribe anytime
For builders

The dataset, one command away.

claude mcp add news-quantified

Then ask Claude: “how does SNZZF react to downgrades?” — or pull it raw via REST.

60-second signup on the NQ portal · 100 free credits/mo
26M+ news records, 2006–2026 Operating since 2012 Point-in-time, zero look-ahead Peer-reviewable methodology (SSRN) ↗